Caulis, Inc. (JP:153A)
:153A
Want to see JP:153A full AI Analyst Report?
153A Stock Chart & Stats
¥2129.00
-¥52.00(-3.54%)
At close: 4:00 PM EST
¥2129.00
-¥52.00(-3.54%)
Day’s Range― - ―
52-Week Range¥958.00 - ¥2,888.00
Previous CloseN/A
Volume54.50K
Average Volume (3M)92.42K
Market Cap
¥11.31B
Enterprise Value¥10.50B
Total Cash (Recent Filing)¥1.88B
Total Debt (Recent Filing)¥250.00M
Price to Earnings (P/E)21.4
Beta1.47
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)22.79
Shares Outstanding6,534,800
10 Day Avg. Volume64,850
30 Day Avg. Volume92,423
Financial Highlights & Ratios
PEG Ratio-7.19
Price to Book (P/B)4.57
Price to Sales (P/S)5.41
P/FCF Ratio36.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA >100% revenue acceleration in 2025 indicates strong product-market fit and demand expansion. Durable revenue growth supports reinvestment, economies of scale, and long-term market share gains, reducing reliance on short-term promotions or one-off contracts.
Profitability / MarginsHigh gross and operating margins signal strong pricing power and scalable software economics. Sustained margin levels provide cash flow for R&D and go-to-market investment, improving resilience to competitive pressure and enabling durable profitability as the company scales.
Balance Sheet StrengthMarked deleveraging and equity growth materially improve financial flexibility and lower financing risk. A very low debt-to-equity ratio reduces refinancing and interest-rate sensitivity, supporting strategic investments and downside protection over the medium term.
Bears Say
Cash Generation VolatilityOperating cash flow fell despite higher revenue and cash conversion from earnings is moderate (~0.40), while free cash flow has declined. This volatility can constrain funding for capex, M&A, or shareholder returns and increases execution risk over the medium term.
Margin CompressionDespite strong absolute margins, recent compression versus prior years suggests rising costs or pricing pressure as the business scales. If structural, this could erode operating leverage and reduce reinvestment capacity unless management restores unit economics.
History Of Financial InstabilityThe balance sheet improvement is recent; prior negative equity and high leverage indicate past financial stress. This legacy raises the importance of monitoring sustainability of improvements, as reversals would materially increase capital and execution risk.
153A FAQ
What was Caulis, Inc.’s price range in the past 12 months?
Caulis, Inc. lowest stock price was ¥958.00 and its highest was ¥2888.00 in the past 12 months.
What is Caulis, Inc.’s market cap?
Caulis, Inc.’s market cap is ¥11.31B.
When is Caulis, Inc.’s upcoming earnings report date?
Caulis, Inc.’s upcoming earnings report date is Aug 19, 2026 which is in 90 days.
How were Caulis, Inc.’s earnings last quarter?
Caulis, Inc. released its earnings results on May 15, 2026. The company reported ¥12.72 earnings per share for the quarter, beating the consensus estimate of N/A by ¥12.72.
Is Caulis, Inc. overvalued?
According to Wall Street analysts Caulis, Inc.’s price is currently Overvalued.
Does Caulis, Inc. pay dividends?
Caulis, Inc. pays a Notavailable dividend of ¥4.8 which represents an annual dividend yield of N/A. See more information on Caulis, Inc. dividends here
What is Caulis, Inc.’s EPS estimate?
Caulis, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Caulis, Inc. have?
Caulis, Inc. has 6,534,800 shares outstanding.
What happened to Caulis, Inc.’s price movement after its last earnings report?
Caulis, Inc. reported an EPS of ¥12.72 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.448%.
Which hedge fund is a major shareholder of Caulis, Inc.?
Currently, no hedge funds are holding shares in JP:153A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Caulis, Inc.
Caulis, Inc. (153A) is a biotechnology company specializing in the development of innovative agricultural solutions and biopesticides aimed at enhancing crop productivity and sustainability. The company focuses on harnessing natural plant-based compounds and advanced biotechnological methods to create products that protect crops from pests and diseases while minimizing environmental impact. Caulis, Inc. operates primarily within the agricultural sector, catering to farmers and agricultural businesses seeking eco-friendly alternatives to traditional chemical pesticides.